Cargando…
Citalopram amplifies the influence of living conditions on mood in depressed patients enrolled in the STAR*D study
Selective serotonin reuptake inhibitors (SSRIs), the most commonly prescribed antidepressant drugs, have a variable and incomplete efficacy. In order to better understand SSRI action, we explored the hypothesis that SSRIs do not affect mood per se but amplify the influence of the living conditions o...
Autores principales: | Chiarotti, F, Viglione, A, Giuliani, A, Branchi, I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416678/ https://www.ncbi.nlm.nih.gov/pubmed/28323288 http://dx.doi.org/10.1038/tp.2017.35 |
Ejemplares similares
-
Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample
por: Peters, Eric J., et al.
Publicado: (2008) -
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR(*)D
por: Adkins, D E, et al.
Publicado: (2012) -
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients
por: Bhattacharyya, Sudeepa, et al.
Publicado: (2019) -
Efficacy and safety of citalopram versus amitriptyline in the treatment of major depression
por: Mathur, Anand, et al.
Publicado: (2005) -
Gene expression biomarkers of response to citalopram treatment in major depressive disorder
por: Mamdani, F, et al.
Publicado: (2011)